​

LENZ Therapeutics Ownership | Who Owns LENZ Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

LENZ Therapeutics Ownership Summary

LENZ Therapeutics is owned by 102.57% institutional investors, 2.53% insiders. Ra capital management is the largest institutional shareholder, holding 14.88% of LENZ shares.

LENZ Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockLENZ Therapeutics102.57%2.53%-5.10%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustryBiotech Stocks 45.22%10.75%44.04%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ra capital management4.18M14.88%$194.65M
Alpha wave global, lp3.61M12.86%$168.26M
Versant venture management2.66M9.46%$123.76M
Blackrock funding, inc. /de1.47M5.25%$68.62M
Vanguard group1.33M4.74%$61.96M
Ubs group1.20M4.28%$55.97M
Paradigm biocapital advisors lp1.07M3.82%$50.00M
72 investment1.02M3.62%$47.41M
Tang capital management897.62K3.20%$41.81M
Rtw investments, lp863.39K3.07%$40.22M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
72 investment1.02M69.77%$47.41M
Versant venture management2.66M58.25%$123.76M
Alpha wave global, lp3.61M17.04%$168.26M
Ally bridge group (ny)175.36K4.97%$8.17M
Plustick management200.00K3.91%$9.32M
Saturn v capital management368.18K3.76%$17.15M
First light asset management693.04K3.04%$32.28M
Ra capital management4.18M2.40%$194.65M
Samsara biocapital343.01K2.09%$15.98M
Tyro capital management100.67K1.74%$4.69M

Top Buyers

HolderShares% AssetsChange
Versant venture management2.66M58.25%2.66M
First light asset management693.04K3.04%693.04K
Franklin resources587.08K0.01%578.52K
Ubs group1.20M0.01%320.13K
Price t rowe associates inc /md/251.13K0.00%236.20K

Top Sellers

HolderShares% AssetsChange
Sectoral asset management---977.25K
Paradigm biocapital advisors lp1.07M1.42%-643.61K
Adage capital partners gp627.62K0.05%-495.12K
Morgan stanley296.22K0.00%-289.14K
Point72 asset management340.00K0.03%-278.14K

New Positions

HolderShares% AssetsChangeValue
Versant venture management2.66M58.25%2.66M$123.76M
First light asset management693.04K3.04%693.04K$32.28M
Plustick management200.00K3.91%200.00K$9.32M
Tyro capital management100.67K1.74%100.67K$4.69M
Neuberger berman group84.01K0.00%84.01K$3.91M

Sold Out

HolderChange
Stephens consulting-1.00
Fortitude family office-9.00
Coldstream capital management-16.00
Assetmark-21.00
Quadrant capital group-27.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202516238.46%28,801,56716.48%1021.32%11543.75%2364.29%
Jun 30, 202511610.48%24,721,51417.75%881.51%7943.64%14-46.15%
Mar 31, 202510616.48%21,119,1009.06%761.51%575.56%2630.00%
Dec 31, 20249319.23%19,863,8136.02%731.54%5630.23%2025.00%
Sep 30, 20247823.81%18,735,645-0.94%681.26%43-4.44%16300.00%

Recent Insider Transactions

DateNameRoleActivityValue
Nov 17, 2025Olsson Shawn Chief Commercial OfficerSell$152.61K
Nov 17, 2025Olsson Shawn Chief Commercial OfficerSell$108.41K
Nov 07, 2025MCCOLLUM JAMES W-Buy$239.28K
Nov 07, 2025Chevallard Daniel R. Chief Financial OfficerBuy$454.20
Nov 07, 2025Chevallard Daniel R. Chief Financial OfficerBuy$49.56K

Insider Transactions Trends

DateBuySell
2025 Q432
2025 Q3-29
2025 Q2-5
2025 Q1--
2024 Q4--

LENZ Ownership FAQ

Who Owns LENZ Therapeutics?

LENZ Therapeutics shareholders are primarily institutional investors at 102.57%, followed by 2.53% insiders and -5.10% retail investors. The average institutional ownership in LENZ Therapeutics's industry, Biotech Stocks , is 45.22%, which LENZ Therapeutics exceeds.

Who owns the most shares of LENZ Therapeutics?

LENZ Therapeutics’s largest shareholders are Ra capital management (4.18M shares, 14.88%), Alpha wave global, lp (3.61M shares, 12.86%), and Versant venture management (2.66M shares, 9.46%). Together, they hold 37.21% of LENZ Therapeutics’s total shares outstanding.

Does Blackrock own LENZ Therapeutics?

BlackRock is not among the top 10 institutional shareholders of LENZ Therapeutics.

Who is LENZ Therapeutics’s biggest shareholder by percentage of total assets invested?

72 investment is LENZ Therapeutics’s biggest shareholder by percentage of total assets invested, with 69.77% of its assets in 1.02M LENZ Therapeutics shares, valued at 47.41M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools